4r7n

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
+
==Fab C2E3==
 +
<StructureSection load='4r7n' size='340' side='right' caption='[[4r7n]], [[Resolution|resolution]] 3.45&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4r7n]] is a 20 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4R7N OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4R7N FirstGlance]. <br>
 +
</td></tr><tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4r7d|4r7d]]</td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4r7n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4r7n OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4r7n RCSB], [http://www.ebi.ac.uk/pdbsum/4r7n PDBsum]</span></td></tr>
 +
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Hu 15C1 is a potent anti-human Toll-like receptor 4 (TLR4) neutralizing antibody. To better understand the molecular basis of its biological activity, we used a multidisciplinary approach to generate an accurate model of the Hu 15C1-TLR4 complex. By combining site-directed mutagenesis, in vitro antibody evolution, affinity measurements and X-ray crystallography of Fab fragments, we identified key interactions across the Hu 15C1-TLR4 interface. These contact points were used as restraints to predict the structure of the Fab region of Hu 15C1 bound to TLR4 using computational molecular docking. This model was further evaluated and validated by additional site-directed mutagenesis studies. The predicted structure of the Hu 15C1-TLR4 complex indicates that the antibody antagonizes the receptor dimerization necessary for its activation. This study exemplifies how iterative cycles of antibody engineering can facilitate the discovery of components of antibody-target interactions.
-
The entry 4r7n is ON HOLD until Paper Publication
+
Robust Antibody-Antigen Complexes Prediction Generated by Combining Sequence Analyses, Mutagenesis, In Vitro Evolution, X-ray Crystallography and In Silico Docking.,Loyau J, Didelot G, Malinge P, Ravn U, Magistrelli G, Depoisier JF, Pontini G, Poitevin Y, Kosco-Vilbois M, Fischer N, Thore S, Rousseau F J Mol Biol. 2015 May 24. pii: S0022-2836(15)00300-9. doi:, 10.1016/j.jmb.2015.05.016. PMID:26013163<ref>PMID:26013163</ref>
-
Authors: Loyau, J., Didelot, G., Malinge, P., Ravn, U., Magistrelli, G., Depoisier, J.F., Kosco-Vilbois, M., Fischer, N., Thore, S., Rousseau, F.
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
 
+
</div>
-
Description: Fab C2E3
+
== References ==
-
[[Category: Unreleased Structures]]
+
<references/>
-
[[Category: Malinge, P]]
+
__TOC__
 +
</StructureSection>
 +
[[Category: Depoisier, J F]]
[[Category: Didelot, G]]
[[Category: Didelot, G]]
[[Category: Fischer, N]]
[[Category: Fischer, N]]
-
[[Category: Thore, S]]
 
-
[[Category: Rousseau, F]]
 
-
[[Category: Depoisier, J.F]]
 
-
[[Category: Ravn, U]]
 
-
[[Category: Magistrelli, G]]
 
[[Category: Kosco-Vilbois, M]]
[[Category: Kosco-Vilbois, M]]
[[Category: Loyau, J]]
[[Category: Loyau, J]]
 +
[[Category: Magistrelli, G]]
 +
[[Category: Malinge, P]]
 +
[[Category: Ravn, U]]
 +
[[Category: Rousseau, F]]
 +
[[Category: Thore, S]]
 +
[[Category: Immune system]]
 +
[[Category: Tlr4 antibody]]

Revision as of 14:37, 29 July 2015

Fab C2E3

4r7n, resolution 3.45Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools